300 related articles for article (PubMed ID: 18950667)
1. Cutaneous biotransformation of N-(4-bromobenzoyl)-S,S-dimethyliminosulfurane and its product, 4-bromobenzamide, leading to percutaneous penetration enhancement of drugs: initial evidence using hydrocortisone.
Sintov AC; Zhang PJ; Michniak-Kohn BB
J Control Release; 2009 Jan; 133(1):44-51. PubMed ID: 18950667
[TBL] [Abstract][Full Text] [Related]
2. Comparison of percutaneous absorption and metabolism of di-n-butylphthalate in various species.
Beydon D; Payan JP; Grandclaude MC
Toxicol In Vitro; 2010 Feb; 24(1):71-8. PubMed ID: 19735722
[TBL] [Abstract][Full Text] [Related]
3. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action.
Novotný M; Klimentová J; Janůšová B; Palát K; Hrabálek A; Vávrová K
J Control Release; 2011 Mar; 150(2):164-70. PubMed ID: 21093505
[TBL] [Abstract][Full Text] [Related]
4. N-(4-bromobenzoyl)-S,S-dimethyliminosulfurane, a potent dermal penetration enhancer.
Strekowski L; Henary M; Kim N; Michniak BB
Bioorg Med Chem Lett; 1999 Apr; 9(7):1033-4. PubMed ID: 10230634
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of 1,4-cyclohexanediol and 1,2-hexanediol on percutaneous absorption and penetration of metronidazole.
Li N; Jia W; Zhang Y; Tan F; Zhang J
Int J Pharm; 2011 Aug; 415(1-2):169-74. PubMed ID: 21669264
[TBL] [Abstract][Full Text] [Related]
6. Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin.
Tsai JC; Shen LC; Sheu HM; Lu CC
Arch Dermatol Res; 2003 Aug; 295(4):169-74. PubMed ID: 12910356
[TBL] [Abstract][Full Text] [Related]
7. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity.
Song Y; Xiao C; Mendelsohn R; Zheng T; Strekowski L; Michniak B
Pharm Res; 2005 Nov; 22(11):1918-25. PubMed ID: 16132348
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.
Altenbach M; Schnyder N; Zimmermann C; Imanidis G
Int J Pharm; 2006 Jan; 307(2):308-17. PubMed ID: 16310991
[TBL] [Abstract][Full Text] [Related]
9. Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot.
Ritschel WA; Panchagnula R; Stemmer K; Ashraf M
Skin Pharmacol; 1991; 4(4):235-45. PubMed ID: 1789985
[TBL] [Abstract][Full Text] [Related]
10. Transfollicular percutaneous absorption. Skin model for quantitative studies.
Illel B; Schaefer H
Acta Derm Venereol; 1988; 68(5):427-30. PubMed ID: 2461027
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous characterization of the insect repellent DEET and the sunscreen oxybenzone from topical skin application.
Kasichayanula S; House JD; Wang T; Gu X
Toxicol Appl Pharmacol; 2007 Sep; 223(2):187-94. PubMed ID: 17602720
[TBL] [Abstract][Full Text] [Related]
12. The effects of freezing skin on transdermal drug penetration kinetics.
Ahlstrom LA; Cross SE; Mills PC
J Vet Pharmacol Ther; 2007 Oct; 30(5):456-63. PubMed ID: 17803739
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous penetration modifiers and formulation effects.
Kaushik D; Costache A; Michniak-Kohn B
Int J Pharm; 2010 Feb; 386(1-2):42-51. PubMed ID: 19900521
[TBL] [Abstract][Full Text] [Related]
14. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies between different rat models for the assessment of percutaneous penetration of hazardous substances.
Korinth G; Göen T; Schaller KH; Drexler H
Arch Toxicol; 2007 Dec; 81(12):833-40. PubMed ID: 17576541
[TBL] [Abstract][Full Text] [Related]
16. The effects of surface preparation on the penetration of hydrocortisone through canine skin.
Ahlstrom LA; Cross SE; Morton JM; Mills PC
Vet J; 2009 Apr; 180(1):48-54. PubMed ID: 18294885
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations.
Reichling J; Landvatter U; Wagner H; Kostka KH; Schaefer UF
Eur J Pharm Biopharm; 2006 Oct; 64(2):222-8. PubMed ID: 16846726
[TBL] [Abstract][Full Text] [Related]
18. The effect of penetration enhancers on drug delivery through skin: a QSAR study.
Ghafourian T; Zandasrar P; Hamishekar H; Nokhodchi A
J Control Release; 2004 Sep; 99(1):113-25. PubMed ID: 15342185
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship for chemical skin permeation enhancers: probing the chemical microenvironment of the site of action.
Warner KS; Li SK; He N; Suhonen TM; Chantasart D; Bolikal D; Higuchi WI
J Pharm Sci; 2003 Jun; 92(6):1305-22. PubMed ID: 12761819
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of different animal skins with human skin in drug percutaneous penetration studies.
Lin SY; Hou SJ; Hsu TH; Yeh FL
Methods Find Exp Clin Pharmacol; 1992 Oct; 14(8):645-54. PubMed ID: 1494304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
